This project is carried out in collaboration with Dr. Maria Waldhoer (InterAx Biotech).

Stage 1

Target modeling

Dynamics of virus attachment.

Stage 3

Proof of concept

First drug candidates will be tested at the end of April 2020 in cell-based assays.

Stage 2

Drug-reprofiling

First hits obtained!

Stage 4

Preparation of clinical trial application